These observations were corroborated by the fact that patients receiving mAFP CP preconditioning showed a higher incidence of liver failure, resulting in elevated liver function parameters such as bilirubin, AST, and AGT, compared to those not supported with mAFP up to 5.0 L/min. The gene discussed is CP; the disease is liver failure.